Moderna Inc
MRNA.O
LATEST TRADE
423.18USD
CHANGE
-6.87(-1.60%)
VOLUME
8,932,434
TODAY'S RANGE
416.51 - 435.45
52 WEEK RANGE
63.64 - 497.49
As of 9:55 AM PDT Sep 20 on the NASDAQ ∙ Minimum 15 minute delay
Previous Close430.05
Open417.51
Volume9,459,968
3M AVG Volume386.61
Today's High435.45
Today's Low416.51
52 Week High497.49
52 Week Low63.64
Shares Out (MIL)403.65
Market Cap (MIL)173,588.10
Forward P/E14.45
Dividend (Yield %)--
9/20/2021
$425.20
MRNA.O
425.20
Advanced Charting
Next Event
Q3 2021 Moderna Inc Earnings ReleaseOct 27, 2021
Latest Developments
More
5 days ago
Moderna Announces Health Canada Approves Its COVID-19 Vaccine
5 days ago
Moderna Highlights New Clinical Data On Its Covid-19 Vaccine
6 days ago
AbCellera Reports Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines
About Moderna Inc
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company has created modalities, including Prophylactic vaccines, Systemic secreted and cell surface therapeutics, Cancer vaccines, Intratumoral immuno-oncology, Localized regenerative therapeutics, and Systemic intracellular therapeutics. Its diverse development pipeline which consists of 27 development candidates across its 24 programs.
INDUSTRY
Biotechnology & Drugs
CONTACT INFO
200 Technology Sq
Cambridge, MA
02139-3578
United States
+1.617.7146500
https://www.modernatx.com/
EXECUTIVE LEADERSHIP
Noubar B. Afeyan
Non-Executive Independent Chairman of the Board, Co-Founder
Stephen Hoge
President
Stephane Bancel
Chief Executive Officer, Director
David W. Meline
Chief Financial Officer
Tracey Franklin
Chief Human Resources Officer
Key Stats
2.69 mean rating - 16 analysts
SELLHOLDBUY
REVENUE (MM, USD)
2018
0.1K
2019
0.1K
2020
0.8K
2021(E)
20.4K
EPS (USD)
2018
-4.950
2019
-1.550
2020
-1.960
2021(E)
29.768
Price To Earnings (TTM)53.68
Price To Sales (TTM)24.73
Price To Book (MRQ)25.85
Price To Cash Flow (TTM)48.28
Total Debt To Equity (MRQ)7.26
LT Debt To Equity (MRQ)4.89
Return On Investment (TTM)65.71
Return On Equity (TTM)35.59
Latest News
Key data on U.S. J&J, Moderna COVID-19 boosters weeks away, Fauci says
Data needed to determine the advisability of booster shots of the Moderna Inc and Johnson & Johnson COVID-19 vaccines is just weeks away, President Joe Biden's chief medical adviser, Dr. Anthony Fauci, said on Sunday.
19 hours ago
Analysis-Torrid Moderna stock rally cools over booster shot doubts
Debate over the need for COVID-19 booster shots is clouding the outlook for Moderna Inc's high-flying shares after the U.S. biotechnology company's stock price soared as much as 360% this year, making it the best performer in the S&P 500.
3 days ago
ANALYSIS-Torrid Moderna stock rally cools over booster shot doubts
Debate over the need for COVID-19 booster shots is clouding the outlook for Moderna Inc's high-flying shares after the U.S. biotechnology company's stock price soared as much as 360% this year, making it the best performer in the S&P 500.
4 days ago
Moderna says COVID-19 vaccine protection wanes, makes case for booster
New data from Moderna Inc's large COVID-19 vaccine trial shows that the protection it offers wanes over time, supporting the case for booster doses, the company said in a news release on Wednesday.
5 days ago
AbCellera and Moderna team up to develop antibody therapies
Peter Thiel-backed AbCellera Biologics Inc said on Wednesday it had entered a multi-year agreement with COVID-19 vaccine maker Moderna Inc to develop antibody therapies for multiple diseases.
6 days ago
Exclusive: WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shot
Efforts to develop an African base for COVID-19 vaccine production will focus on trying to replicate Moderna's shot, but a lack of progress in talks with the U.S. company mean the project will take time, a senior WHO official told Reuters.
6 days ago
Takeda eyes vaccine business growth as dengue, COVID-19 shots progress - CEO
Takeda Pharmaceutical Co, which distributes Moderna Inc's COVID-19 shots in Japan, expects vaccines to become a bigger part of its portfolio as shots for dengue fever and COVID-19 near regulatory approval, its chief executive said.
7 days ago
Australia buys additional 1 million doses of Moderna's COVID-19 vaccine
Australia has purchased an additional 1 million doses of Moderna's COVID-19 vaccine from the European Union, Prime Minister Scott Morrison said, as the country accelerates its inoculation programme to fight record high infections.
9 days ago
COVID-19 vaccines hold strong against Delta, protection waning in older adults
Three U.S. studies suggest COVID-19 vaccines offer strong protection against hospitalization and death, even in the face of the highly transmissible Delta variant, but vaccine protection appears to be waning among older populations, especially among those 75 and older.
10 days ago
Moderna working on combination COVID-19 vaccine booster and flu shot
Moderna Inc said on Thursday it is developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot.
11 days ago
Moderna developing single-dose, combination vaccine for COVID-19, flu
Moderna Inc said on Thursday it was developing a single-dose vaccine that combines a booster dose against COVID-19 and a booster against flu.
12 days ago
Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says
Top U.S. infectious disease expert Dr. Anthony Fauci said on Sunday that officials were likely to soon get the regulatory go-ahead to administer COVID-19 vaccine booster shots made by Pfizer, although Moderna booster could take a little longer.
16 days ago
Moderna seeks EU authorization for COVID-19 vaccine booster dose
Moderna Inc said on Friday it had asked the EU drugs regulator for conditional approval of a booster shot of its COVID-19 vaccine at a 50 microgram dose.
17 days ago
Moderna submits application for COVID-19 booster dose to EU regulator
Moderna Inc said on Friday it has submitted for conditional approval of a booster dose of its COVID-19 vaccine at a 50 microgram dose level to the EU drugs regulator. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)
17 days ago
U.S. shipped more than 2 million COVID-19 doses to Kenya and Ghana
The United States on Thursday shipped more than 2 million doses of Moderna's COVID-19 vaccine to Kenya and Ghana on Thursday through the COVAX global distribution program, a White House official said.
18 days ago
CORRECTED-(OFFICIAL)-U.S. to begin shipping COVID-19 doses to Kenya and Ghana
The United States will begin shipping more than 2 million doses of Moderna's COVID-19 vaccine to Kenya and Ghana on Thursday through the COVAX global distribution program, a White House official said.
18 days ago
Moderna seeks U.S. authorization for COVID-19 vaccine booster
Moderna Inc on Wednesday asked the U.S. Food and Drug Administration (FDA) to allow the use of a third booster dose of its COVID-19 vaccine.
19 days ago
Moderna submits initial data for COVID-19 vaccine booster to U.S. FDA
Moderna Inc said on Wednesday it had initiated submission of data to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine.
19 days ago
Antibody levels higher after Moderna shot; Lilly arthritis drug used with steroid cuts death risk
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.
19 days ago
U.S. administers third dose of COVID-19 vaccine to over 1 million people - CDC
The United States has administered a third dose of either Pfizer Inc-BioNTech or Moderna Inc's COVID-19 vaccines to over 1 million people since Aug. 13, when regulators authorized an additional shot for immunocompromised people.
19 days ago
U.S. administers third dose of COVID-19 vaccine to over 1 million people - CDC
The United States has administered a third dose of either Pfizer Inc or Moderna Inc's COVID-19 vaccines to over 1 million people as of Wednesday morning, the U.S. Centers for Disease Control and Prevention said.
19 days ago
Moderna to recall COVID-19 doses in Japan after stainless steel contaminants found
Moderna Inc and Takeda Pharmaceutical Co Ltd on Wednesday said they are working with Japanese authorities to recall three batches of COVID-19 vaccine after an investigation found stainless steel contaminants in some vials.
20 days ago
Britain to give third COVID-19 vaccine doses to immunosuppressed
Britain will give severely immunosuppressed people a third dose of COVID-19 vaccine to increase their chances of generating a better immune response, although officials stressed the offer was separate from any broader booster vaccine programme.
20 days ago
Japan finds another Moderna vial suspected to contain foreign substance
Japan reported a fresh contamination case involving Moderna's COVID-19 vaccine, the fourth such incident in less than a week, threatening to slow the country's sputtering inoculation campaign.
20 days ago
Moderna says Takeda plans to recall three lots of suspended COVID-19 vaccine
Moderna Inc said on Wednesday its Japanese distribution partner, Takeda Pharmaceutical Co Ltd, planned to initiate the recall of three lots of its COVID-19 vaccine that were suspended due to contamination.
20 days ago
Japan finds stainless steel particles in suspended Moderna shots, health risk low
Japan's health ministry said on Wednesday that contaminants found in suspended Moderna Inc COVID-19 vaccines were particles of stainless steel, and it did not expect they would pose an additional health risk.
20 days ago
Japan finds another Moderna vial suspected to contain foreign substance
Japan's Kanagawa prefecture said it has found another vial of Moderna Inc's COVID-19 vaccine suspected of containing a foreign substance and has put the rest of the lot on hold.
20 days ago
Explainer-What we know about Japan's contaminated Moderna COVID-19 vaccines
Japan's COVID-19 vaccination push suffered a blow from widening reports of contamination in supplies of Moderna Inc's vaccine.
21 days ago
Japan health minister says Okinawa vaccine contaminants likely from needle stick
Japan's health minister said on Tuesday it was highly likely that foreign matter found in Moderna Inc COVID-19 vaccines in the southern prefecture of Okinawa were caused when needles were stuck into the vials.
21 days ago
Japan's Moderna vaccine contamination woes widen as regions put holds on more shots
Moderna Inc's COVID-19 vaccine contamination woes in Japan widened after two regions put temporary holds on shots following the discovery of foreign substances in more batches.
21 days ago
CDC says no deaths reported among young adults due to heart inflammation after COVID-19 shots
The U.S. Centers for Disease Control and Prevention said no deaths had been reported in young adults after a rare heart inflammation known as myocarditis, a known side effect of COVID-19 vaccines made by Pfizer Inc and Moderna.
22 days ago
EXPLAINER-What we know about Japan's contaminated Moderna COVID-19 vaccine supplies
Japan's COVID-19 vaccination push has been dealt a blow by widening reports of contamination in supplies of Moderna Inc's COVID-19 vaccine.
22 days ago
Japan's Gunma prefecture reports contaminant in Moderna COVID-19 vaccine
A contaminant was found in Moderna's COVID-19 vaccine on Sunday in Japan's Gunma prefecture, near Tokyo, the latest such case in the country involving the U.S. company's vaccines. A tiny, black substance was found in a Moderna Inc vaccine vial, prompting the prefecture to...
22 days ago
Japan eyes mixed use of COVID-19 shots to speed vaccine rollout
Japan is looking into the possibility of mixing shots of AstraZeneca Plc's COVID-19 vaccine with those developed by other drug makers in a bid to speed up its vaccine rollout, the minister in charge of vaccinations said on Sunday.
23 days ago
Okinawa finds contaminants in Moderna COVID-19 vaccines- NHK
Contaminants were found in Moderna Inc's COVID-19 vaccines at a large-scale vaccination centre in Japan's Okinawa prefecture, suspending inoculations, public broadcaster NHK reported on Sunday.
23 days ago
Two die in Japan after shots from suspended Moderna vaccines - Japan govt
Two people died after receiving Moderna Inc COVID-19 vaccine shots that were among lots later suspended following the discovery of contaminants, Japan's health ministry said on Saturday.
24 days ago
Two die in Japan after shots from suspended Moderna vaccines - Japan govt
Two people died after receiving Moderna COVID-19 vaccine shots that were among lots later suspended following the discovery of contaminants, Japan's health ministry said on Saturday.
24 days ago
NIH starts study of COVID-19 booster shot in people with autoimmune diseases
The National Institutes of Health (NIH) is testing a booster shot of COVID-19 vaccines in people with autoimmune diseases who have not responded well to the primary vaccine course.
24 days ago
Moderna vaccine production continues in EU amid contamination probe
Production of Moderna COVID-19 vaccines at a plant in Spain can continue, the European Union drugs regulator said on Friday, while it carries out its investigation of a suspected metallic contamination incident.
25 days ago
Canada approves Moderna's COVID-19 vaccine for adolescents
Canada on Friday authorized the use of Moderna Inc's COVID-19 vaccine in adolescents, with the country's health regulator calling it safe and effective for the 12 to 17 age-group.
25 days ago
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.
Apps​Newsletters​Advertise with UsAdvertising Guidelines​Cookies​Terms of UsePrivacyDo Not Sell My Personal Information
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All Rights Reserved.
U.S. plans to require vaccines for most non-U.S.-citizen air travelers starting in early November